ECB profit increased in 2018
Photo by Adobe Stock

Financial Statements of the ECB for 2018

Press Release Provided By ECB

ECB profit increased by €0.3 billion to €1.6 billion in 2018 (2017: €1.3 billion) and is distributed in full to national central banks
Net interest income on securities held for monetary policy purposes: €1.2 billion (2017: €1.1 billion)
ECB’s Balance Sheet grew to €447 billion (2017: €414 billion)
The European Central Bank’s (ECB’s) audited financial statements for 2018 show that the profit for the year increased by €301 million, to €1,575 million, mainly as a result of higher net interest income earned on the US dollar portfolio and on the asset purchase programme (APP) portfolio.

Net interest income totalled €2,277 million in 2018 (2017: €1,812 million). Net interest income on foreign reserve assets increased to €862 million (2017: €534 million) owing to higher interest income earned on the US dollar portfolio. Net interest income arising from the APP increased by €245 million, to €820 million, as a result of the continuing securities purchases under this programme and the higher yields of the securities acquired during the year compared to the historical yield of the portfolio. Conversely, as a result of redemptions, net interest income earned under the Securities Markets Programme (SMP) decreased to €384 million (2017: €447 million). The ECB’s interest income from its SMP holdings of Greek government bonds amounted to €127 million (2017: €154 million).

Realised losses arising from financial operations amounted to €77 million (2017: realised gains €161 million), owing to realised price losses generated in the US dollar portfolio.

Write-downs amounted to €69 million (2017: €105 million), primarily as a result of a decrease in the market value of a number of securities held in the US dollar portfolio alongside an increase in the corresponding yields.

Impairment tests are conducted on the securities held by the ECB in its monetary policy portfolios, which are valued at amortised cost (subject to impairment). Based on the results of these tests, no impairment losses have been recorded for these portfolios.

The fees charged to supervised entities amounted to €518 million (2017: €437 million). These fees are charged in order to recover expenses incurred by the ECB in the performance of its supervisory tasks. The increase in 2018 relates predominantly to work associated with comprehensive assessments and EBA stress testing.

Total staff costs decreased to €515 million (2017: €535 million) owing to a non-recurring charge included in 2017 in relation to post-employment, other-long term and termination benefits for ECB staff. Other administrative expenses increased to €599 million (2017: €539 million), mainly owing to the increase in expenses related to the ECB’s supervisory tasks.

The ECB’s net profit is distributed to the euro area national central banks (NCBs). The Governing Council decided to make an interim profit distribution, amounting to €1,191 million, to the euro area NCBs on 31 January 2019. At yesterday’s meeting, the Governing Council decided to distribute the remainder of the profit, amounting to €384 million, on 22 February 2019.

The total size of the ECB’s Balance Sheet increased by 8% to €447 billion (2017: €414 billion). This increase was mainly due to the securities purchased under the APP.

The continuing purchases of securities under the APP led to an increase in the consolidated balance sheet of the Eurosystem, which rose by 5% to €4,702 billion (2017: €4,468 billion). The Eurosystem’s holdings of securities held for monetary policy purposes increased by €265 billion to €2,651 billion (2017: €2,386 billion). The APP holdings increased by €284 billion to €2,570 billion, while securities held under the first two covered bond purchase programmes and the SMP declined by €2 billion and €16 billion respectively owing to redemptions.

For media queries, please contact William Lelieveldt, tel.: +49 69 1344 7316.

Notes:

Further details on the financial accounting and reporting policies of the ECB and the Eurosystem and on the ECB’s annual accounts can be found on the ECB’s website under the Accounting and reporting and Annual accounts sections, respectively.
Eurosystem SMP holdings: The table below presents the breakdown by issuer country of the outstanding amounts of the Eurosystem’s SMP holdings as at 31 December 2018.

Total Eurosystem SMP holdings by issuer country as at 31 December 2018

Issuer Country Nominal amount
(EUR billions)
Book Value [1]
(EUR billions)
Average remaining maturity
(years)
Ireland 5.8 5.7 1.7
Greece 8.3 7.8 2.1
spain 14.2 14.2 1.7
Italy 40.7 40.2 1.5
Portugal 5.3 5.3 1.6
Total[2] 74.3 73.1 1.7

[1]SMP holdings are valued at amortised cost.

[2]Totals may not add up due to rounding.

European Central Bank
Directorate General Communications
Sonnemannstrasse 20, 60314 Frankfurt am Main, Germany
Tel.: +49 69 1344 7455, E-mail: media@ecb.europa.eu
Website: www.ecb.europa.eu
Source:

Financial statements of the ECB for 2018

The European Central Bank (ECB) is the central bank of the 19 European Union countries which have adopted the euro. Our main task is to maintain price stability in the euro area and so preserve the purchasing power of the single currency.

Check Also

Market Research

China Payments Landscape 2018-2022: Card-based, E-commerce, Mobile Proximity, P2P, Bill, Alternative Payments, Payment Innovations, Infrastructure & Regulation

In an attempt to reduce fraud and promote the healthy and sustainable development of mobile payment services, China's central bank the People's Bank of China (PBOC) issued the Bar Code Payment Service Specification to regulate QR and barcode payments in December 2017. The regulation caps payments made by traditional QR codes to CNY500 ($76.86) per day; this can be extended up to CNY5,000 ($768.55) if the payment transaction is verified by two or more authenticating parties such as digital certificates and digital signatures. If a third-party payment institution provides payment services with this technology, it must obtain a network payment service license.

Pepsico Image

The PepsiCo Foundation Partners with CARE to Tackle Gender Inequality in Agriculture with an $18.2 Million Investment in She Feeds the World Grant will provide resources and training to 5 million women farmers and their families worldwide to help them increase crop yields and income

News Provided By PepsiCo FoundationMar 04, 2019, 16:05 ET PURCHASE, N.Y., March 4, 2019 /PRNewswire/ …

GDP Growth Slowed

US Economy Starts to Slow Entering 2019, but Headwinds Ease

The Federal Reserve has signaled that it will postpone further interest rate hikes until signs of rising inflation emerge and cease balance sheet normalization activities towards the end of this year. Stock price gains since the announcement of these policy shifts illustrate that if they are executed, business confidence is likely to rise.

Where can I get business financing?

Horizon Technology Finance Provides Investment Portfolio Update Increases Portfolio Size with $24 Million in Loan Originations; Grows Committed Backlog to $47 Million

"During the third quarter, we experienced solid investment activity, increasing the size of our portfolio and expanding our committed backlog for the second consecutive quarter," said Gerald A. Michaud, President of Horizon. "Our success funding seven loans, totaling more than $24 million, and growing our committed backlog to $47 million underscores the strong demand for our venture debt products to growing life science and technology companies. We believe Horizon will continue to benefit from a robust pipeline of investment opportunities and is well positioned to deliver long-term, disciplined portfolio growth, while ensuring credit quality remains strong."

Litigation Photo

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

The investigation concerns whether the Immune Design board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Immune Design shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given that one Wall Street analyst has a $9.00 price target on the stock and the Company has approximately $100 million in cash and no long-term debt.

Mergers and Acquisitions

Merck to Acquire Immune Design; Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

“Scientists at Immune Design have established a unique portfolio of approaches to cancer immunization and adjuvant systems designed to enhance the ability of a vaccine to protect against infection, which could meaningfully improve vaccine development," said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “This acquisition builds upon Merck’s industry-leading programs that harness the power of the immune system to prevent and treat disease.”

SEC Files Charges in Elaborate Microcap Stock Fraud

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawfully obtain shares in microcap companies, which they then dumped on unsuspecting retail investors,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “This action demonstrates the resolve of the SEC in pursuing fraudsters who use elaborate financing schemes to engage in securities fraud.”

%d bloggers like this: